Thornton J Douglas, Anyanwu Precious, Tata Vaishnavi, Al Rawwad Tamara, Fleming Marc L
PharmD, PhD, BCPS. College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston. Houston, TX (United States).
PharmD. College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy, University of Houston. Houston, TX (United States).
Pharm Pract (Granada). 2020 Jan-Mar;18(1):1682. doi: 10.18549/PharmPract.2020.1.1682. Epub 2020 Feb 24.
This study was conducted to assess pharmacists' practices when counseling patients on their prescription medications, and their preferences for training.
Five focus group discussions of community pharmacists (n=45, with seven to eleven participants in each group) were conducted in a major metropolitan city in the southern United States. Participants were recruited via email using a list of community pharmacists provided by the Texas State Board of Pharmacy. All focus group discussions were structured using a moderator guide consisting of both discrete and open-ended questions. Qualitative analysis software was used to analyze the data with a thematic analysis approach.
The participants in this study had a high self-efficacy regarding their ability to counsel on both new and opioid prescriptions. Many pharmacists experienced the same barriers to counseling and agreed on the components of counseling. However, the themes that emerged showed that the participants exhibited only a partial understanding of the components of counseling. The themes that emerged in the thematic analysis were perceived confidence and discordant counseling practices, inadequate infrastructure, lack of comprehensive counseling, inconsistent use of the Prescription Drug Monitoring Program (PDMP), and pharmacists' desired training/assistance.
Community pharmacists are in a unique position to help combat the opioid crisis; however, there has been very little research on the pharmacist-patient interaction in this context. With policy changes, such as the PDMP mandate, going into effect across the country, it is important to capitalize on the potential community pharmacists have in ameliorating the opioid crisis in the United States.
本研究旨在评估药剂师在为患者提供处方药咨询时的实践情况以及他们对培训的偏好。
在美国南部一个主要大都市对社区药剂师进行了五次焦点小组讨论(n = 45,每组七至十一名参与者)。通过电子邮件使用德克萨斯州药房委员会提供的社区药剂师名单招募参与者。所有焦点小组讨论均使用由离散和开放式问题组成的主持人指南进行组织。使用定性分析软件采用主题分析方法对数据进行分析。
本研究中的参与者对他们在新处方和阿片类药物处方咨询方面的能力具有较高的自我效能感。许多药剂师在咨询方面遇到相同的障碍,并就咨询的组成部分达成一致。然而,出现的主题表明参与者对咨询的组成部分仅表现出部分理解。主题分析中出现的主题包括感知到的信心和不一致的咨询实践、基础设施不足、缺乏全面咨询、处方药监测计划(PDMP)使用不一致以及药剂师期望的培训/帮助。
社区药剂师在帮助应对阿片类药物危机方面具有独特地位;然而,在这种背景下关于药剂师与患者互动的研究非常少。随着诸如PDMP授权等政策变化在全国生效,利用社区药剂师在美国缓解阿片类药物危机方面的潜力非常重要。